PONTI, Giovanni

	Titolo	Data di pubblicazione	Autore(i)
1	Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA)	2008	G. Ponti; L. Losi; G. Pellacani; G. B. Rossi; L. Presutti; F. Mattioli; D. Villari; L. Wannesson; M. Alicandri-Ciufelli; P. Izzo; M. De Rosa; P. Marone; S. Seidenari
2	Wall paintings facies and their possible genetic correlates in the ancient Pompeii: A bio-anthropologic message from the past?	2016	Ponti, Giovanni; Manfredini, Marco; Ruini, Cristel
3	Variegated Dermoscopy of in situ Melanoma.	2012	S. Seidenari ;S. Bassoli ;S. Borsari ;C. Ferrari ;F. Giusti ;G. Ponti ;C. Tomasini ;C. Magnoni
4	Variabilità fenotipica e caratterizzazione biomolecolare in otto famiglie con diagnosi di Muir-Torre.	2004	Ponti G
5	Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas	2006	G. Ponti; L. Losi; M. Pedroni; E. Lucci-Cordisco; C. Di Gregorio; G. Pellacani; S. Seidenari
6	The value of fluorimetry (Qubit) and spectrophotometry (NanoDrop) in the quantification of cell-free DNA (cfDNA) in malignant melanoma and prostate cancer patients	2018	Ponti, Giovanni; Maccaferri, Monia; Manfredini, Marco; Kaleci, Shaniko; Mandrioli, Mauro; Pellacani, Giovanni; Ozben, Tomris; Depenni, Roberta; Bianchi, Giampaolo; Pirola, Giacomo Maria; Tomasi, Aldo
7	Value and prognostic significance of mitotic rate in a retrospective series of pT1 cutaneous malignant melanoma patients	2011	G. Ponti; A. Pollio; A.M. Cesinaro; G. Pellacani; C. Magnoni; S. Seidenari
8	Unicystic ameloblastoma associated with the novel K729M PTCH1 mutation in a patient with nevoid basal cell carcinoma (Gorlin) syndrome.	2012	Ponti G.;Pollio A.;Mignogna M.D.;Pellacani G.;Pastorino L.;Bianchi-Scarrà G.;Di Gregorio C.;Magnoni C.;Azzoni P.;Greco M.;Seidenari S.
9	Two different marker panels for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations.	2002	Pedroni M; Borghi F; Lamberti I; Scarselli A; Menigatti M; Ponti G; Benatti P; Losi L; Di Gregorio C; Abbati G; Rossi G; Roncucci L; Ponz de Leon M
10	Two different marker panels for microsatellie instability analysis in detection of constitutional MLH1 and MSH2 mutations.	2002	Pedroni M.; Borghi F.; Lamberti I.; Scarselli A.; Menigatti M.; Ponti G.; Benatti P.; Losi L.; Di Gregorio C.; Abbati G.; Rossi G.; Roncucci L.; Ponz De Leon M.
11	Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.	2004	Ponz de Leon M; Marino M; Benatti P; Rossi G; Menigatti M; Pedroni M; Di Gregorio C; Losi L; Borghi F; Scarselli A; Ponti G; Roncari B; Zangardi G; Abbati G; Ascari E; Roncucci L
12	The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations.	2013	G Ponti; G Pellacani; A Tomasi; F Gelsomino; A Spallanzani; Depenni R; S Al Jalbout; L Simi; L Garagnani; S Borsari; A Conti; C Ruini; A Fontana; G Luppi.
13	The impact of histopathologic diagnosis on the proper management of testis neoplasms.	2008	Ponti G.;Ponzoni M.;Ferreri A.J.;Foppoli M.;Mazzucchelli L.;Zucca E.
14	The dermoscopic variability of pigment network in melanoma in situ.	2012	Seidenari S;Ferrari C;Borsari S;Bassoli S;Cesinaro AM;Giusti F;Pellacani G; Ponti G. ;Zalaudek I;Argenziano G
15	Stem cell properties in cell cultures from different stage of melanoma progression.	2014	C. Magnoni; S. Guidice; G. Pellacani; G. Bertazzoni; C. Longo; E. Veratti; D. Morini; L. Benassi; S. Al Jalbout; C. Vaschieri; P. Azzoni; A. De Pol°; S. Seidenari; A. Tomasi; G. Ponti
16	Sphenoid asymmetry associated to other skeletal anomalies in a clear cut case of PTCH1 mutated Gorlin-Goltz syndrome: a novel finding?	2013	Ruini C; Pastorino L; Malagoli M; Ghiorzo P; Bianchi Scarrà G; Loschi P; Pellacani G; Tomasi A; Farnetani F; Pollio A; Mandel VD; Ponti G.
17	Skeletal stigmata as keys to access to the composite and ancient Gorlin-Goltz syndrome history: The Egypt, Pompeii and Herculaneum lessons	2016	Ponti, Giovanni; Pellacani, Giovanni; Tomasi, Aldo; Sammaria, Giuliano; Manfredini, Marco
18	Skeletal and cranio-facial signs in Gorlin syndrome from ancient Egypt to the modern age: sphenoid asymmetry in a patient with a novelPTCH1mutation	2014	Giovanni Ponti;Cristel Ruini;Lorenza Pastorino;Pietro Loschi;Annarita Pecchi;Marcella Malagoli;Victor Desmond Mandel;Rosa Boano;Andrea Conti;Giovanni Pellacani;Aldo Tomasi
19	Seminal cell-free DNA molecular profile as a novel diagnostic and prognostic prostate cancer biomarkers	2018	Ponti, Giovanni; Maccaferri, Monia; Manfredini, Marco; Cotugno, Michele; Pellacani, Giovanni; Conti, Andrea; Micali, Salvatore; Mandrioli, Mauro; Tomasi, Aldo
20	Seminal cell-free DNA assessment as a novel prostate cancer biomarker	2018	Ponti, Giovanni; Maccaferri, Monia; Mandrioli, Mauro; Ozbenc, Tomris; Manfredini, Marco; Micali, Salvatore; Cotugno, Michele; Bianchi, Giampaolo; Pellacani, Giovanni; Tomasi, Aldo